MADELYN TUFEKCIOGLU: Open Payments
NPI 1467164988 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 27 payments from 9 companies in 2025. Trend: 2023 $54 · 2024 $178 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $92 |
| Merck Sharp & Dohme LLC | 5 | $85 |
| BridgeBio Pharma, Inc. | 4 | $72 |
| PFIZER INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| ABIOMED | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: CAMZYOS, VERQUVO, Attruby, VYNDAQEL, JARDIANCE, UPTRAVI, FARXIGA, Kerendia.
Industry payments across NJ — which companies pay providers there.
